Studies have shown that TERC expression is elevated in 20–21% of mild dysplasia (CIN I), 50–68% of moderate dysplasia (CIN II), 81–82% of severe dysplasia (CIN III), and 95–100% in invasive cancers [176, 177]. The gene discussed is TERC; the disease is dysplasia.